{
    "2020-05-17": [
        [
            {
                "time": "2023-10-10",
                "original_text": "400亿定增资金“围猎”医药生物股",
                "features": {
                    "keywords": [
                        "400亿",
                        "定增资金",
                        "围猎",
                        "医药生物股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "高瓴资本连下三城背后 400亿定增资金“围猎”医药生物股",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "连下三城",
                        "400亿",
                        "定增资金",
                        "围猎",
                        "医药生物股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}